The ACR/CHEST ILD Guidelines in Practice: Watch the Webinar Recording Now!

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

Search results for: hip OA

Novel Bone Drug Promising in Postmenopausal Osteoporosis

Reuters Staff  |  

NEW YORK (Reuters Health)—The investigational drug romosozumab led to gains in hip bone mineral density (BMD) that were not seen with teriparatide in older women with osteoporosis transitioning from bisphosphonate therapy in the STRUCTURE study. Amgen’s romosozumab is a monoclonal antibody that inhibits sclerosin, a negative regulator of bone formation. In addition to stimulating bone…

U.S. Senate Mulls Bare-Bones Healthcare Bill; Marathon of Voting Expected

Yasmeen Abutaleb and Susan Cornwell  |  

WASHINGTON (Reuters)—U.S. Senate Republicans embarked on Thursday on another push to unravel Obamacare, working on a stripped-down bill after failing to pass broader legislation and complete a seven-year campaign to gut a law that extended health coverage to millions. Republicans leaders hope a so-called skinny bill can draw enough votes to pass despite unified Democratic…

Obamacare Repeal Battle Back on Senate Floor

Richard Cowan  |  

WASHINGTON (Reuters)—After a months-long struggle, Republicans have succeeded in bringing Obamacare repeal legislation, a centerpiece of their 2016 election campaigns, to a debate on the U.S. Senate floor. Now the hard part begins. Republicans, deeply divided over the proper role of the government in helping low-income people receive healthcare, eked out a procedural win on…

Collaborative Guideline Addresses the Perioperative Use of Antirheumatic Drug Therapy

  |  

A new guideline developed by the ACR and the American Association of Hip and Knee Surgeons addresses the perioperative use of antirheumatic drug therapy. Specifically, it provides recommendations on the use of traditional disease-modifying antirheumatic drugs, biologic agents, tofacitinib and glucocorticoids in adults with RA; SpA, including ankylosing spondylitis and psoriatic arthritis; JIA; or SLE undergoing elective THA or TKA. The guideline provides recommendations regarding when to continue, when to withhold and when to restart these medications, and the optimal perioperative dosing of glucocorticoids…

Progress Made During HOD Annual Meeting

Gary L. Bryant, MD, FACR, FACP  |  

The AMA House of Delegates (HOD) met in Chicago for its annual meeting June 9–14. More than 530 HOD members were present, with several hundred AMA and association staff and guests. As I am sure you have noted from past issues of ACR@Work, the ACR is in its five-year membership review. The ACR must be…

The Important Role of the AMA RVS Update Committee in Medicare Payments

Timothy J. Laing, MD  |  

Believe it or not, change begins with one person willing to lead by example—and you can be that person. All too often, we get caught up with the changes we want. However, instead of talking about what we would like, it’s time to lead. The best way to do this is to show others you’re…

RheumPAC’s 2017 Q2 Progress Report Shows Increased Investments, Participation

  |  

Members’ voices are crucial to making an impact on policies that have an impact on healthcare. Here, we’d like to thank members who have invested in the first half of this year, yielding $16,000 more than was raised over the same time period last year. In response to an in-depth examination of RheumPAC in 2016,…

Anti-CarP May Play Special Role in RA-Associated Mortality

  |  

Researchers may have established a relationship between a new RA autoantibody, anti-carbamylated protein (anti-CarP) antibodies, and increased mortality risk. The recent study showed that anti-CarP was the only autoantibody associated with mortality, specifically respiratory system cause of death…

Trump Urges U.S. Senate Republicans to Keep Trying on Healthcare Bill

Amanda Becker and Susan Cornwell  |  

WASHINGTON (Reuters)—U.S. President Donald Trump pushed Senate Republicans on Wednesday to take another stab at repealing or overhauling Obamacare, urging them at a White House meeting to keep their campaign promises and find a new healthcare approach. “We’re close. We’re very close,” Trump said at the start of the lunch meeting, a day after the…